التصنيف: respiratory distress syndrome (rds) المادة الفعالة:beractant
indication survanta is indicated for prevention and treatment (ï-rescueï-) of respiratory distress syndrome (rds) (hyaline membrane disease) in premature infants. survanta significantly reduces the incidence of rds mortality due to rds and air leak compli
